Changes in Farr radioimmunoassay and EliA fluorescence immunoassay anti-dsDNA in relation to exacerbation of SLE
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Measuring anti-dsDNA levels could support treatment adjustment during follow-up of patients with systemic lupus erythematosus (SLE). We investigated whether patients with exacerbations of SLE showed changes in anti-double-stranded DNA (anti-dsDNA) levels prior to the exacerbation using the Farr and EliA assay and examined which assay showed highest specificity and predictive value for exacerbations. Changes in anti-dsDNA of ≥25% prior to exacerbation were considered of clinical significance. Exacerbations were retrospectively abstracted from medical records. Eighteen of 48 patients showed one or more exacerbations. We found 22 exacerbations with complete lab work-up, all accompanied by ≥25% change in anti-dsDNA in one or both assays. Only 10 exacerbations showed concordant changes in anti-dsDNA in both assays. Changes in anti-dsDNA had a low predictive value for exacerbations of SLE, but the specificity of anti-dsDNA changes for patients with exacerbations was higher for EliA than Farr. We conclude that despite the limited relation between anti-dsDNA changes and exacerbations of SLE, anti-dsDNA testing could still support clinical decision making when used in the correct setting. We conclude that EliA is preferable over Farr for assaying anti-dsDNA during follow-up of patients with SLE because of higher specificity, less “hands-on” time and absence of radioactivity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A positive correlation was reported for FEIA [41], [68] and for CIA [48], [67].”
From Laboratory evaluation of anti-dsDNA antibodies. (2022) · cites this paper as [68]
Citations
Cites
Hochberg, M. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400928 · Cited by 11,409
Hahn, B. H., McMahon, M. A., Wilkinson, A., Wallace, W. D., Daikh, D. I., FitzGerald, J. D., Karpouzas, G. A., Merrill, J. T., Wallace, D. J., Yazdany, J., et al. (2012) · Arthritis Care & Research · doi:10.1002/acr.21664 · Cited by 1,463
Bertsias, G., Ioannidis, J. P. A., Boletis, J., Bombardieri, S., Cervera, R., Dostal, C., Font, J., Gilboe, I. M., Houssiau, F., Huizinga, T., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.070367 · Cited by 762
Ter Borg, E. J., Horst, G., Hummel, E. J., Limburg, P. C., & Kallenberg, C. G. M. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330505 · Cited by 572
Bauer, J. W., Petri, M., Batliwalla, F. M., Koeuth, T., Wilson, J., Slattery, C., Panoskaltsis‐Mortari, A., Gregersen, P. K., Behrens, T. W., & Baechler, E. C. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24803 · Cited by 297
Fifty years of anti-ds DNA antibodies: are we approaching journey's end?
Isenberg, D. A., Manson, J. J., Ehrenstein, M. R., & Rahman, A. (2007) · Rheumatology · doi:10.1093/rheumatology/kem112 · Cited by 281
Esdaile, J. M., Abrahamowicz, M., Joseph, L., MacKenzie, T., Li, Y., & Danoff, D. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390304 · Cited by 177
Yee, C., Farewell, V. T., Isenberg, D. A., Rahman, A., Teh, L., Griffiths, B., Bruce, I. N., Ahmad, Y. A., Prabu, A., Akil, M., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.23130 · Cited by 116
Bootsma, H., Spronk, P. E., Borg, E. J. T., Hummel, E. J., de Boer, G., Limburg, P. C., & Kallenberg, C. G. M. (1997) · Annals of the Rheumatic Diseases · doi:10.1136/ard.56.11.661 · Cited by 115
Petri, M., Singh, S., TESFASYONE, H., & MALIK, A. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.090019 · Cited by 89
Research works printed but not linked: 1
- 10.1002/1529-0131(200110)44:10<2342::AID-ART397>3.0.CO;2-8 · doi:10.1002/1529-0131(200110)44:10<2342::aid-art397>3.0.co;2-8
Cited by
Anti-DNA antibodies–quintessential biomarkers of SLE
Pisetsky, D. S. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.151 · Cited by 267
Predictive biological markers of systemic lupus erythematosus flares: a systematic literature review
ACRONIM, O. B. O. T. F., Gensous, N., Marti, A., Barnetche, T., Blanco, P., Lazaro, E., Seneschal, J., Truchetet, M.-E., Duffau, P., & Richez, C. (2017) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1442-6 · Cited by 99
“7% [27] to 100% [30], specificity from 13% [26] to 89.”
BackgroundMethodInfluentialRose, T., Grützkau, A., Klotsche, J., Enghard, P., Flechsig, A., Keller, J., Riemekasten, G., Radbruch, A., Burmester, G. R., Dörner, T., et al. (2017) · Rheumatology · doi:10.1093/rheumatology/kex220 · Cited by 61
Bentow, C., Lakos, G., Martis, P., Wahl, E., Garcia, M., Viñas, O., Espinosa, G., Cervera, R., Sjöwall, C., Carmona-Fernandes, D., et al. (2016) · Lupus · doi:10.1177/0961203316640917 · Cited by 37
Ghiggeri, G. M., D’Alessandro, M., Bartolomeo, D., Degl’Innocenti, M. L., Magnasco, A., Lugani, F., Prunotto, M., & Bruschi, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225799 · Cited by 37
Metadata
- Authors
- Hillebrand, J., Moens, H. B., & Mulder, A.
- Affiliations
- Clinical Chemistry Laboratory
- Department of Rheumatology, Ziekenhuisgroep Twente, the Netherlands
- Venue
- Lupus
- Publisher
- SAGE Publications
- Published
- 2013-08-08
- Volume
- 22
- Issue
- 11
- Pages
- 1169-1173
- ISSN
- 0961-2033 (ISSN-L)
- 1477-0962
- OpenAlex
- W1988052826
- Cited by
- 21
- References
- 15
- Citations by year
- 2026: 2 · 2024: 4 · 2022: 2 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 1 · 2017: 2 · 2016: 3 · 2015: 3
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Lupus (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
- Keywords
- systemic lupus erythematosus, anti-dsDNA antibodies, disease exacerbation, assay comparison, predictive value, assay specificity
- MeSH terms
- Adolescent, Adult, Aged, Antibodies, Antinuclear, Female, Fluorescent Antibody Technique, Humans, Lupus Erythematosus, Systemic, Male, Middle Aged, Radioimmunoassay, Retrospective Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Changes in Farr radioimmunoassay and EliA fluorescence immunoassay anti-dsDNA in relation to exacerbation of SLE. https://app.cochat.ai/papers/10.1177/0961203313500368
- The paper
- Hillebrand, J., Moens, H. B., & Mulder, A. (2013). Changes in Farr radioimmunoassay and EliA fluorescence immunoassay anti-dsDNA in relation to exacerbation of SLE. Lupus. https://doi.org/10.1177/0961203313500368
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.